7,397 Intuitive Surgical, Inc. $ISRG Shares Acquired by Waycross Partners LLC

Waycross Partners LLC boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.6% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 71,310 shares of the medical equipment provider’s stock after buying an additional 7,397 shares during the period. Intuitive Surgical accounts for 2.2% of Waycross Partners LLC’s portfolio, making the stock its 21st biggest holding. Waycross Partners LLC’s holdings in Intuitive Surgical were worth $28,997,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently bought and sold shares of the company. North Point Portfolio Managers Corp OH bought a new stake in shares of Intuitive Surgical during the 3rd quarter worth about $27,000. John Boyer Inc. acquired a new stake in shares of Intuitive Surgical in the 3rd quarter worth approximately $27,000. Compass Wealth Management LLC bought a new position in shares of Intuitive Surgical in the third quarter valued at approximately $29,000. Main Street Group LTD bought a new position in shares of Intuitive Surgical in the first quarter valued at approximately $30,000. Finally, Compass Financial Management LLC bought a new position in shares of Intuitive Surgical in the second quarter valued at approximately $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 3.4%

Shares of NASDAQ ISRG traded down $15.72 during midday trading on Friday, reaching $452.80. The company’s stock had a trading volume of 2,150,343 shares, compared to its average volume of 2,506,658. The company has a 50 day moving average price of $409.93 and a 200 day moving average price of $431.89. Intuitive Surgical, Inc. has a one year low of $328.57 and a one year high of $603.88. The company has a market cap of $156.96 billion, a price-to-earnings ratio of 54.75, a price-to-earnings-growth ratio of 3.01 and a beta of 1.45.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. The firm had revenue of $3.05 billion during the quarter, compared to analysts’ expectations of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The firm’s revenue for the quarter was up 21.7% compared to the same quarter last year. During the same period last year, the firm posted $2.40 earnings per share. Research analysts anticipate that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Craig H. Barratt sold 1,150 shares of Intuitive Surgical stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $443.80, for a total value of $510,370.00. Following the transaction, the director directly owned 1,150 shares in the company, valued at $510,370. The trade was a 50.00% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary S. Guthart sold 20,095 shares of the business’s stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $451.61, for a total value of $9,075,102.95. Following the sale, the director directly owned 1,204,530 shares in the company, valued at $543,977,793.30. This trade represents a 1.64% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 49,928 shares of company stock valued at $21,917,367 in the last three months. Insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the topic of several recent analyst reports. Zacks Research raised Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a report on Thursday, October 22nd. Stifel Nicolaus decreased their price target on Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating for the company in a research note on Friday, July 17th. Barclays reaffirmed an “overweight” rating and set a $500.00 price target (up from $485.00) on shares of Intuitive Surgical in a research note on Wednesday, October 21st. Citigroup lowered their price target on Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating on the stock in a research report on Friday, July 17th. Finally, Leerink Partners set a $503.00 price objective on Intuitive Surgical and gave the stock an “outperform” rating in a research note on Wednesday, October 21st. One analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $493.54.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Da Vinci system placements increased 28% year over year to 546 in the third quarter of 2026, and net placements rose 40%, expanding the installed base and supporting future revenue from instruments and services. Article: ISRG System Placements Rise 28%
• Neutral Sentiment: Analysts caution that the placement jump may have been driven partly by multisystem orders and upgrades, so it does not necessarily signal a broad-based increase in hospital capital spending or guarantee the pace will continue. Article: ISRG System Placements Rise 28%: Is Capital Equipment Demand Rising?
• Neutral Sentiment: Recent Zacks coverage says ISRG is attracting investor attention but, in the information provided, identifies no new fundamental development that would explain a change in the stock’s prospects. Article: ISRG is Attracting Investor Attention
• Negative Sentiment: Directors Gary Guthart and Craig Barratt reported sales of 10,000 and 1,150 shares, respectively. Both transactions were made under pre-arranged Rule 10b5-1 plans, which may lessen their signaling significance, but insider selling can still add a modest sentiment headwind. SEC filing: Gary Guthart transaction SEC filing: Craig Barratt transaction

Intuitive Surgical Profile